Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Framework vs Gimme Care

Framework
Graded #230

Lower grade

vs+19.5
Gimme Care
Graded #23

Higher grade

The verdict

Gimme Care takes it — 84.6/100 to 65.1/100.

Gimme Care grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Mid-value both-molecule pricing ($130/$163), verified, and nationwide.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueGimme Care +9
80
89
Dose & formulationGimme Care +16
64
80
Clinical oversightGimme Care +12
72
84
Labs & monitoringGimme Care +30
52
82
FulfillmentGimme Care +30
57
87
Contract termsGimme Care +44
41
85
Framework · left barGimme Care · right bar

The numbers

MetricFrameworkGimme Care
WeighScore65.1/10084.6/100
GradeCB
Scorecard rank#230#23
Semaglutide$100/mo (starting dose, compounded)$130/mo
Tirzepatide$100/mo (starting dose, compounded)$163/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Framework

Graded #230 · C

Strengths

  • Named 503B pharmacy partner (The Pharmacy Hub) disclosed — the FDA-registered outsourcing-facility pathway, distinct from 503A
  • Publishes the FDA compounded-medication disclaimer
  • $25/week pricing (~$100/mo) is among the most aggressive in the directory
  • $0 membership fees
  • Phone support published, toll-free (888) 412-0666

Where it loses points

  • LegitScript ID / certification not shown on the homepage
  • States-served list not disclosed
  • Medical director / clinical leadership not disclosed
  • Corporate legal entity not disclosed (no footer copyright)
  • Governing law / arbitration venue not stated
Gimme Care

Graded #23 · B

Strengths

  • $130 sema / $163 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Not the cheapest tier
  • Injection-only
  • Monitoring detail limited

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard